EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Reassessing Ivabradine: Potential Benefits and Risks in Atrial Fibrillation Therapy

Dorsa Alijanzadeh, Shahrzad Moghim, Paniz Zarand, Mohammad Ali Akbarzadeh, Yasaman Zarinfar, Isa Khaheshi iD

Cardiovascular Drugs and Therapy · 2025

DOI: 10.1007/s10557-024-07652-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Drugs and Therapy, 2025. Verfasst von Dorsa Alijanzadeh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Atrial Fibrillation, Benzazepines, Anti-Arrhythmia Agents, Cardiovascular Agents. Die Arbeit nennt 91 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationBenzazepinesAnti-Arrhythmia AgentsCardiovascular AgentsHumansIvabradineHeart RateAnimalsTreatment OutcomeRisk Assessment

Stichwörter der Autor:innen

Antiarrhythmic drugsAtrial fibrillationIvabradineRate controlSinoatrial node

Substanzen

IvabradineBenzazepinesAnti-Arrhythmia AgentsCardiovascular Agents

Autor:innen und Institutionen

  • Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran.
  • School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. isa_khaheshi@yahoo.com.

ORCID-Profile: Isa Khaheshi

Zitieren

APA

Alijanzadeh, D., Moghim, S., Zarand, P., Akbarzadeh, M. A., Zarinfar, Y., & Khaheshi, I. (2025). Reassessing Ivabradine: Potential Benefits and Risks in Atrial Fibrillation Therapy. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-024-07652-3

Vancouver

Alijanzadeh D, Moghim S, Zarand P, Akbarzadeh MA, Zarinfar Y, Khaheshi I. Reassessing Ivabradine: Potential Benefits and Risks in Atrial Fibrillation Therapy. Cardiovascular Drugs and Therapy. 2025. doi:10.1007/s10557-024-07652-3

BibTeX
@article{Alijanzadeh2025,
  author = {Alijanzadeh, Dorsa and Moghim, Shahrzad and Zarand, Paniz and Akbarzadeh, Mohammad Ali and Zarinfar, Yasaman and Khaheshi, Isa},
  title = {Reassessing Ivabradine: Potential Benefits and Risks in Atrial Fibrillation Therapy},
  journal = {Cardiovascular Drugs and Therapy},
  year = {2025},
  doi = {10.1007/s10557-024-07652-3}
}
Kostenlos starten →